Compare Surya Biru Murni Acetylene Tbk. (SBMA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Surya Biru Murni Acetylene Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Surya Biru Murni Acetylene Tbk. trades at Rp111 (market cap 101.36B, 1.37M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Surya Biru Murni Acetylene Tbk. and Organon Pharma Indonesia Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| SBMA | SCPI | |
|---|---|---|
Market Cap | 101.36B | 104.4B |
Volume | 1.37M | — |
Lot | 13.68K | — |
Turnover | 148.72M | — |
Average Price | 108.68 | — |
Value | 148.72M | — |
Indicative Equilibrium Price | 111 | — |
Indicative Equilibrium Volume | 1.25K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Surya Biru Murni Acetylene Tbk.
PT Surya Biru Murni Acetylene Tbk (the Company) was established in Balikpapan based on Notarial Deed No. 57 of Mohamad Rasjid Umar, S.H., dated October 25, 1980. The Company started its commercial operations in 1982.
Read more on SBMA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
